Use of Gadolinium-Based Contrast Agents in Kidney Disease Patients: Time for Change
Am J Kidney Dis
.
2020 Sep;76(3):436-439.
doi: 10.1053/j.ajkd.2020.03.011.
Epub 2020 Apr 10.
Author
Ali K Abu-Alfa
1
Affiliation
1
Division of Nephrology and Hypertension, American University of Beirut, Beirut, Lebanon; Section of Nephrology, Yale School of Medicine, New Haven, CT. Electronic address: abualfa@aub.edu.lb.
PMID:
32283121
DOI:
10.1053/j.ajkd.2020.03.011
No abstract available
Publication types
Editorial
Comment
MeSH terms
Contrast Media
Gadolinium
Humans
Magnetic Resonance Imaging
Nephrogenic Fibrosing Dermopathy*
Renal Insufficiency, Chronic*
Substances
Contrast Media
Gadolinium